ApicHope Pharmaceutical Group Co., Ltd. (SHE:300723)

SHE:300723 Revenue

ApicHope Pharmaceutical Group had revenue of 124.81M CNY in the quarter ending September 30, 2026, a decrease of -45.78%. This brings the company's total for the last twelve months to 734.80M, down -28.27% year-over-year. In the year 2025, ApicHope Pharmaceutical Group had annual revenue of 932.27M, down -35.72%. That makes ApicHope Pharmaceutical Group the 21,934th largest company in the world by revenue and 4,008th in China.

• Revenue (ttm): 734.80M
• Revenue Growth: -28.27%
• P/S Ratio: 18.18
• Revenue / Employee: 567.85K
• Employees: 1,294
• Market Cap: 13.36B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceutical Manufacturing 896.98M 96.2%
• Pharmaceutical Agents and Others 35.29M 3.8%

Fiscal year ended Dec 31, 2025 See the full SHE:300723 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	932.27M	-517.96M	-35.72%
Dec 31, 2024	1.45B	-1.05B	-42.07%
Dec 31, 2023	2.50B	223.25M	9.79%
Jan 1, 2023	2.28B	80.98M	3.68%
Dec 31, 2021	2.20B	523.80M	31.26%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error